Satellos Bioscience Inc. Common StockMSLE

$5.71-0.14 (-2.39%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$105M

Micro-cap

+19%

2026 — today

10-Year Price

+0%

2026 — today

52-Week Range

$5.59$13.01

Current $5.71· 2%

Satellos Bioscience, Inc. is a regenerative medicine firm dedicated to creating novel therapeutic solutions. The company employs its proprietary MyoReGenX™ technology platform, which enables the identification of stem cell regeneration deficits within various muscle diseases and subsequently facilitates the development of targeted treatments. Frank Gleeson and Michael Rudnicki established the company on July 27, 2012, and its corporate headquarters are located in Toronto, Canada.

Valuation in context

P/E ratio

-3.3

N/A

Not meaningful — company is unprofitable

P/B ratio

1.5

Near historic low

Near historic low — last 10 years

FCF Yield

-24.4%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when MSLE is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.